The ophthalmic trigeminal (opV) placode exclusively gives rise to sensory neurons, making it a good model to study the molecular regulation of sensory neurogenesis. A number of signaling pathways including Wnt, PDGF, FGF, and Notch have been shown to be involved in the process of opV placode cell development. However, the regulatory relationships between these signaling pathways in placode cells are still unknown and have been difficult to study experimentally. Using a novel multifactorial approach in chick embryos that allows for in- 
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Introduction
In vertebrates, areas of head ectoderm termed cranial placodes and a subset of neural crest cells give rise to all peripheral sensory neurons of the cranial ganglia (D' Amico-Martel and Noden, 1983) . Most neural precursor tissue can give rise to multiple cell types; however, the ophthalmic trigeminal placode (opV) contributes only sensory neurons within the trigeminal ganglion, making it a unique model for the study of sensory neurogenesis (Begbie et al., 2002) .
For the past decade, core publications have helped characterize the function of genes and signaling pathways known to be active in opV placode development; Pax3 and FGF, as well as the canonical Wnt and Notch/Delta signaling pathways are all active here (Canning et al., 2008; Dude et al., 2009; Lassiter et al., 2007 Lassiter et al., , 2009 Lassiter et al., , 2010 ).
Molecular pathways in sensory neurogenesis
FGF signaling has been shown to be involved in the development of not only the opV placodes. As examples, localized FGF signaling induces uncommitted ectoderm lateral to the developing hindbrain to develop the vertebrate inner ear (reviewed by Ohyama et al., 2006; Schimmang, 2007; Ladher et al., 2010) . Disruption of FGF3 and FGF8 signaling by SU5402, an FGF receptor antagonist, blocks critical steps in the development of the otic placode. In zebrafish it has also been shown that FGF signaling must be active through mid-somitogenesis stages to maintain otic placode cell fate (Leger and Brand, 2002) . Additionally, FGF signaling is required for the development of the lens placode in mice (Garcia et al., 2011) .
In the opV placode domain in chick, initial expression of FGFR4 mRNA occurs at the 10 somite stage (ss), shortly after expression of Pax3, an early marker of opV placode cells (Stark et al., 1997) . Individual opV placode cells express FGFR4 transiently just prior to and during delamination, and peak expression occurs concomitantly with peak neurogenesis at the 15-28 ss. FGFR4 expression is quickly downregulated in each cell coincident with delamination, and is therefore not detected in the condensing trigeminal ganglion (Stark et al., 1997) . Studies in which FGF signaling was blocked with the dominantnegative secreted-FGFR4 (sFGFR4) gene fragment prevented cellular delamination from placodal ectoderm to the spot of future ganglion formation, indicating that FGF signaling is required for delamination and differentiation during opV sensory neurogenesis (Lassiter et al., 2009 ).
In the Notch/Delta signaling pathway, a well-known regulator of cellular and neuronal differentiation, the transmembrane Notch receptor is activated by the membrane-bound Delta or Serrate ligands. The function of Notch signaling can be viewed as a switch that regulates developmental choices (Lewis, 1998) . Many studies have characterized the general rule that precocious neuronal differentiation occurs when Notch signaling is blocked while neuronal differentiation is inhibited when Notch signaling is activated (Abelló et al., 2007; Bolos et al., 2007; Daudet et al., 2007; Kageyama et al., 2005; Lewis, 1998; Nelson et al., 2007; Yoon and Gaiano, 2005) . In sensory neurogenesis, reduced Notch signaling in the avian dorsal root ganglion resulted in the generation of DRG neurons, while Notch activation prevented neuronal differentiation but permitted glial differentiation in vitro (Wakamatsu et al., 2000) . Lassiter et al. (2010) carefully characterized the expression of several Notch signaling pathway components as part of their functional assessment of Notch signaling in trigeminal placode development. For example, Ngn2, which induces the expression of Delta1 (Castro et al., 2006) and is inhibited by the Notch effector gene Hes1 (Shimojo et al., 2008) , is first expressed in the opV placode at~10-11 ss, with more robust expression at~16 ss, indicating that the timing of Notch downregulation is coincident with peak FGFR4 expression and neuronal differentiation. In the same study, inhibition of Notch signaling by the gammasecretase inhibitor DAPT resulted in premature and enhanced neuronal differentiation, while misexpression of the Notch intracellular domain blocked neuronal differentiation. From these results it was concluded that Notch signaling is a primary regulator of the sensory neuron cell fate in the trigeminal placodes, with downregulation of Notch signaling being required for neurogenesis (Lassiter et al., 2010) .
Pathway interactions in development
Although several components involved in sensory neurogenesis have been identified, a more complete regulatory model of trigeminal sensory neurogenesis, including how these pathways complement one another, has not been formed. This study primarily aims to determine the crosstalk and hierarchy between FGF and Notch signaling in sensory neurogenesis. Even in other well-described developmental systems, this question is somewhat unclear. For example, it has been known for some time that FGF and Notch signaling contribute to somite segmentation (Goldbeter et al., 2007) , where it is proposed that these pathways work in coordination to regulate somite formation periodicity through a molecular oscillator known as the segmentation clock. It has been suggested that Notch signaling acts as a regulator switch in somite segmentation, with many of its target genes displaying cyclic expression, while FGF signaling is thought to act upstream and/or parallel to this pathway (Gibb et al., 2010) . Consistent with this theory, Notch knockout mice showed a complete disruption of somitogenesis (Ferjentsik et al., 2009) . Further, evidence from mutant mice with disrupted FGF signaling resulted in a decrease of the Notch target Lunatic Fringe, which suggests that FGF at least in part regulates Notch signaling (Wahl et al., 2007) . In contrast, however, inhibition of Notch activity in zebrafish does not completely disrupt somite segmentation, and therefore may be coordinating a Notch-independent oscillator, while FGF target genes control oscillations (Lewis, 2009; Ozbudak and Pourquie, 2008; Kawamura et al., 2005) . A recent review highlights a model wherein Hes7 lies at the interface between Notch and FGF signaling in somitogenesis (Harima and Kageyama, 2013) . Although the interplay between the FGF and Notch signaling pathways in somitogenesis is becoming clearer, how the information applies to other systems is unknown.
Interactions between FGF and Notch have also been shown in neuroepithelial precursor mouse cells where FGF activates Notch signaling thereby inhibiting neuronal differentiation (Faux et al., 2001 ). In contrast however, it has been shown that activation of Notch signaling in NIH 3T3 cells suppresses FGF-dependent cellular transformation, indicating that Notch may lie upstream of FGF in this developmental context, or work through an autoregulatory mechanism (Small et al., 2003) .
Results from these studies suggest that Notch and FGF can interact in a variety of developmental contexts. As described, the mechanism of this interaction is dependent on the cell type and organism. The potential interactions of Notch and FGF in the development of trigeminal sensory neurons could be distilled down to three potential mechanisms: First, FGF signaling (through transient FGFR4 upregulation) may act to downregulate Notch signaling, thereby allowing neurogenesis to proceed. Second, reduced Notch signaling activity may stimulate transient but robust FGFR4 expression, leading to high FGF signaling and neurogenesis. Finally, FGF and Notch may be acting in parallel (i.e. both involved, but no discernible cross-talk) to induce sensory neuron formation.
The purpose of this study was to determine the regulatory relationship between the FGF and Notch signaling pathways in sensory neurogenesis using the trigeminal placode model. To do this, we used a novel approach that allowed us to manipulate multiple signaling pathways simultaneously by combining existing experimental approaches. FGF and Notch were blocked concomitantly, and variables such as Pax3 and FGFR4 expression, expression of neurogenesis markers, and basement membrane integrity were assessed. From the results, we propose a model wherein the Notch and FGF signaling pathways act in parallel to promote basement membrane breakdown and sensory neurogenesis.
Results
Global inhibition of FGF and Notch signaling inhibits neurogenesis
It was previously shown that cells in the opV placode treated with SU5402 fail to delaminate and contribute to the ganglion (Lassiter et al., 2009) . In contrast, inhibition of Notch in opV placode cells leads to premature neuronal differentiation with increased expression of the proneural marker Islet1 in the ectoderm and mesenchyme early in differentiation (Lassiter et al., 2010) . To define the relationship between FGF and Notch signaling in opV neurogenesis, we employed a novel approach to simultaneously manipulate multiple signaling pathways.
In order to determine whether FGF signaling, likely through FGFR4 activation, acts to inhibit Notch, FGF signaling was inhibited with the FGF receptor antagonist SU5402 while at the same time Notch signaling was inhibited with DAPT in 12-14 ss embryos. This experiment inhibits each pathway slightly before peak delamination and differentiation of opV placode cells and is designed to test whether Notch inhibition can rescue the inhibitory effects on neurogenesis seen when blocking FGF signaling (Lassiter et al., 2009) . If the hypothesis that FGF acts endogenously to downregulate Notch signaling is true, then experimental downregulation of Notch (via DAPT treatment) would promote neurogenesis even when blocking FGF signaling. If diminished neurogenesis is observed, however, then FGF signaling cannot be singly responsible for endogenous Notch inhibition.
After embryos were prepared as described, they were incubated in agar wells containing either DMSO, 50 µM SU5402, 200 µM DAPT, or a combination of 50 µM SU5402 plus 200 µM DAPT (SU5402 + DAPT) and allowed to incubate for 24 hours to the 24-28 ss. Following incubation, embryos were cryosectioned and immunostained for the opV marker Pax3 and the proneural marker Islet1.
Embryos treated only with SU5402 revealed a significant decrease in the average number of Pax3+/Islet1+mesenchyme cells per section (8.35; SEM ± 2.34; n = 4) when compared with DMSO controls (17.1; SEM ± 2.34; n = 5), a difference of 14.76 cells/ placode section (p = 0.0489; Fig. 1B,F; Fig. 2 ). These data are comparable with results obtained in a previous study that characterized the effect of SU5402 on head explant cultures in the opV placode domain (Lassiter et al., 2009) .
In embryos where Notch signaling was blocked alone, robust neuronal differentiation occurred, consistent with data published by Lassiter et al. (2010) . DAPT treated embryos had an average of 47.1 cells/section with co-localization of Pax3 and Islet1 (SEM ± 3.31; n = 2) in the mesenchyme; a significant increase from DMSO controls (p < 0.0001; Fig To analyze dual inhibition of FGF and Notch, both pathways were blocked simultaneously with SU5402 and DAPT (SU5402 + DAPT). Remarkably, the combined treatment greatly reduced the average number of co-expressing Pax3 and Islet1 cells in the mesenchyme (8.8; SEM ± 2.10) compared to DAPT and DMSO controls (p < 0.0001, p = 0.0489; Fig. 1D,H ). In fact, there was no statistical difference when compared to embryos treated with SU5402 alone (p = 0.9989; Fig. 2) .
Results from these experiments indicate that combined inhibition of Notch and FGF signaling mimics the results of FGF inhibition alone, showing significantly reduced neurogenesis. From this it can be concluded that FGF signaling alone does not act as a negative regulator of Notch signaling.
sFGFR4 misexpression combined with Notch inhibition blocks neurogenesis
While global inhibition of FGF and Notch signaling with SU5402 and DAPT allowed us to evaluate all potential opV neurons, it is possible that disruption of FGF signaling outside the opV placode affected differentiation indirectly. For example, it is possible that global inhibition of FGF resulted in a downregulation of Wnt signaling in the neural tube, which is thought to be involved in the development and maintenance of opV progenitor cells (Lassiter et al., 2007) . To ensure that the results obtained from embryos treated with SU5402 + DAPT were not a reflection of a non-cell autonomous mechanism, FGF signaling was blocked via electroporation into the head ectoderm of 6-9 ss embryos with secreted-FGFR4 (sFGFR4), while simultaneously inhibiting Notch signaling with DAPT. sFGFR4 is a previously described misexpression construct (Marics et al., 2002) which acts to inhibit FGF signaling by expressing only the extracellular domain (the first~860 coding base pairs) of the molecule, thereby competing away endogenous FGF ligand but not transducing a signal. This approach matches that employed previously to show the cell-autonomous effects of blocking FGF signaling in the opV placode (Lassiter et al., 2009 ). Targeted cells in experimental embryos electroporated with the sFGFR4 construct were identified by the expression of Green Fluorescent Protein (GFP) driven by a separate SV40 promoter within the sFGFR4 plasmid. Cells in control embryos electroporated with the pCIG construct were also identified by the expression of GFP driven by a promoter within the pCIG plasmid. Following electroporation, all embryos were allowed to incubate on an agar-albumen substrate with DMSO. After 4 hours, a sufficient time for the electroporated construct to begin being expressed, Notch signaling was blocked by transferring experimental embryos to an agar-albumin substrate containing 200 µM DAPT. All embryos were incubated and collected 24 hours later at the 24-28 ss. Experimental and control embryos were labeled as pCIG + DMSO, sFGFR4 + DMSO, pCIG + DAPT and sFGFR4 + DAPT. Embryos were prepared for cryosectioning as described and immunostained with the proneural marker Islet1.
It had been previously shown that Pax3 was downregulated in sFGFR4 targeted cells (but apparently not in adjacent, untargeted cells) by the 28 ss, or within 30 hours after electroporation, in electroporated embryos (Lassiter et al., 2009 ). Therefore, Pax3 was only minimally detectable in some targeted cells. This made it an unusable marker for cell counts, but a valuable tool in identifying the opV placode/ganglion region. In contrast, Pax3 expression is maintained in embryos treated with SU5402, although at weaker levels than in control embryos. Therefore, in these experiments, Pax3 expression was used only as a landmark for the opV placode/ganglion region, while Islet1, which is expressed in a few ectodermal placode cells at the onset of differentiation and is maintained through the differentiation process, was used to identify differentiating neurons.
Similar to results published in Lassiter et al. (2009) , embryos electroporated with sFGFR4 and cultured in DMSO (sFGFR4 + DMSO) showed a dramatic decrease in the number of GFP-labeled cells co-expressing the proneural marker Islet1 in the mesenchyme when compared with pCIG controls cultured in DMSO (Fig. 3A-F) . In sFGFR4 + DMSO embryos (n = 7) very few GFP+/Islet1+ cells were found contributing to the future opV ganglion in the mesenchyme while embryos electroporated with pCIG and cultured in DMSO (pCIG + DMSO; n = 11) had an We also confirmed that cells targeted by electroporation with pCIG and cultured in DAPT (pCIG + DAPT) result in increased expression of the proneural marker Islet1 in the mesenchyme (Lassiter et al., 2010, Fig. 3G-I ). An average of 7.85 GFP+/ Islet1+ cells/section (SEM ± 0.45) were found in the mesenchyme in pCIG + DAPT treated embryos (n = 17), a significant increase compared to the pCIG + DMSO controls (p < 0.0001, Fig. 4) .
In order to determine the relationship between these findings, the FGF and Notch signaling pathways were simultaneously blocked by electroporating sFGFR4 and later culturing with DAPT (sFGFR4 + DAPT; Fig. 3J-L) . Quantitative analysis of these embryos showed an average of just 0.3 GFP+/Islet1+ cells/ section in the mesenchyme (SEM ± 0.62) which was a significant decrease from pCIG + DMSO (p = 0.002) and pCIG + DAPT (p < 0.0001) treated embryos. As with SU5402/DAPT treated embryos, the number of GFP+/Islet1+ cells in the mesenchyme of sFGFR4 + DAPT treated embryos was not statistically different from sFGFR4 + DMSO treated embryos (p = 0.9880; Fig. 4) .
Electroporating with sFGFR4 allowed analysis after blocking FGF signaling in individual cells. These data agree with the results obtained from SU5402 experiments, where neurogenesis is significantly reduced. Taken together, these findings strongly suggest that Notch repression is unable to overcome FGF inhibition, again suggesting that FGF does not act upstream of Notch downregulation in the pathway to neurogenesis.
FGFR4 expression in response to Notch inhibition
Since FGF inhibition resulted in reduced neurogenesis even with simultaneous inhibition of Notch, the hypothesis that FGF activation leads to downregulation of Notch signaling to promote neurogenesis is false. Next, the hypothesis that Notch inhibition leads to upregulation of FGFR4 in opV placode cells was tested. FGFR4 mRNA expression within the opV placode domain initially occurs in a few cells shortly after Pax3 expression, with the number of cells expressing FGFR4 increasing and peaking with the peak of placode cell delamination at about the 15-25 ss. From thorough observation, FGFR4 is upregulated in cells preparing to delaminate, and then is quickly downregulated as the cells enter the mesenchyme. Thus, a transient upregulation is observed (Lassiter et al., 2009; Stark et al., 1997) . To assess expression in the context of diminished Notch activity, FGFR4 mRNA expression was assessed after blocking the Notch pathway with DAPT. Knowing that assessing endogenous FGFR4 expression at its peak might confound the results, we looked for premature expansion of FGFR4 (in response to Notch inhibition) at a slightly earlier stage, but still within the temporal domain of responsiveness to Notch inhibition (i.e. significant increase in the number of cells expressing Islet1 after DAPT treatment). It is also important to note that transient expression would still be expected, but that more cells would enter this phase simultaneously, being revealed by in situ hybridization.
Six to nine ss embryos were prepared as described and treated with 200 µM DAPT for 4 or 12 hours. Following DAPT treatment, mRNA expression was analyzed by in situ hybridization. While some variability was seen between embryos, the overall results showed that DAPT treated embryos expressed similar patterns of FGFR4 expression as DMSO treated controls (Fig. 5) , with no striking increase in expression after Notch inhibition. These results suggest that placodal FGFR4 expression is not regulated by Notch. These combined with earlier results instead support a model where the two pathways act in parallel to promote neurogenesis in the opV placode.
Global inhibition of FGF and Notch does not lead to premature differentiation in the ectoderm
While the data presented here provided good evidence of how blocking both FGF and Notch signaling impacts the differentiation of opV placode cells, some subtle observations made us want to examine in more detail how blocking each pathway, or blocking both, affects the ectodermal/mesenchymal state of placode cells. To do this, embryos were grown to the 12-14 ss and treated with DMSO, 50 µM SU5402, 200 µM DAPT, or a combination of 50 µM SU5402 plus 200 µM DAPT (SU5402 + DAPT) in an agar-albumin substrate and allowed to incubate for 24 hours. Following incubation, embryos were collected, cryosectioned, and prepared for immunostaining to detect Pax3 and Islet1.
As described, embryos treated with SU5402 contributed significantly fewer differentiating cells to ganglion formation compared to controls (Fig. 1B,F) . Analysis of ectoderm cells in the opV placode treated with SU5402 revealed few co-expressing Pax3/Islet1 cells per section, similar to controls (1.25 SEM ± 0.71 vs. 2.55 SEM ± 0.71; p = 0.5747). Reduced FGF signaling did not therefore significantly change the Pax3/Islet1 expression profile within the ectoderm, but cells failed to delaminate. Once stalled in the ectoderm, cells failed to differentiate as neurons in the ectoderm.
In concurrence with Lassiter et al. (2010) , DAPT treated embryos contained significantly more Pax3+/Islet1+ cells per section in the ectoderm (8.50 SEM ± 1.01) compared to controls (p < 0.0001; Fig. 1 ). However, dual inhibition of FGF (with SU5402) and Notch (with DAPT) resulted in few co-expressing Pax3/Islet1 cells per section in the ectoderm (3.56 SEM ± 0.64), not statistically different from DMSO or SU5402 treated embryos (p = 0.7188; p = 0.0845). Thus, it appears that dual inhibition of FGF and Notch again left cells stalled in the ectoderm, similar to SU5402 treatment alone.
To ensure that the analysis of ectoderm cells in SU5402 experiments was not affected by global FGF inhibition, or to test cell autonomous inhibition of FGF with concurrent inhibition of Notch, 6-9 ss embryos electroporated with sFGFR4 and cultured in DMSO or DAPT and collected at the 24-28 ss were also analyzed and compared to controls (pCIG + DMSO or DAPT). Following incubation, embryos were collected, cryosectioned, and immunostained for Islet1, with Pax3 being used as a landmark to identify the opV placode/ganglion region. We first blocked the FGF pathway alone and compared our results to published data from Lassiter et al. (2009) . We found that cells expressing the sFGFR4 construct in the ectoderm rarely coexpressed Islet1 24 hours after electroporation and did not express Islet1 36 hours after electroporation. Our results showed that pCIG + DMSO treated embryos contained significantly fewer GFP expressing cells per section in opV placodal ectoderm (17.5, SEM ± 1.48) when compared with sFGFR4 + DMSO treated embryos (24.85, SEM ± 1.80; p = 0.0055). However, the combined total number of GFP+ cells per section in the ectoderm and mesenchyme (i.e. total number of targeted cells) was not significantly different (pCIG + DMSO, 23.29 ± 1.73 vs. sFGFR4 + DMSO, 25.27 ± 2.10; p = 0.8847). Most GFP+ cells in the ectoderm of sFGFR4 + DMSO and pCIG + DMSO treated embryos did not co-express Islet1 (0.90, SEM ± 0.25; 0.52, SEM ± 0.31). Similar to results published in Lassiter et al. (2009) , these data suggest that cells expressing the sFGFR4 construct do not delaminate and do not contribute to ganglion formation ( Fig. 3D-F) .
Recall that embryos electroporated with pCIG and treated with DAPT showed significantly more cells per section coexpressing GFP and Islet1 in the ectoderm vs. pCIG + DMSO controls (p = 0.0003; normalized for total GFP+ cells), but no difference in total number of ectodermal GFP+ cells (p = 0.9900). Compared to sFGFR4 + DMSO treated embryos, pCIG + DAPT treated embryos contained significantly fewer GFP+ cells in the ectoderm (p = 0.0055). These findings support data reported in Lassiter et al. (2010) and suggest that Notch inhibition by DAPT causes cells to undergo premature differentiation in the ectoderm, while not affecting cellular delamination as assayed by the total number of targeted cells in the ectoderm.
To combine these approaches, 6-9 ss embryos were electroporated with sFGFR4 and transferred from an albuminagar substrate containing DMSO to an albumin-agar substrate containing DAPT after 4 hours (to allow for sFGFR4 expression prior to Notch inhibition). Results showed that there was a significant reduction in the number of GFP/Islet1 co-expressing cells in the ectoderm when compared to pCIG + DAPT control embryos (p < 0.0001). As with GFP+ cells in sFGFR4/DMSO treated embryos, GFP+ cells in sFGFR4/DAPT treated embryos remained in the ectoderm and failed to delaminate.
To summarize, few ectoderm cells express Islet1 in control embryos or in embryos in which the FGF pathway is blocked by any mechanism, with or without concurrent inhibition of Notch. Interestingly, Pax3 and Islet1 expression after SU5402 treatment appears similar to that observed in control embryos, suggesting that failed differentiation is not immediately conveyed. These data provide further evidence that cells treated with SU5402 or cells misexpressing sFGFR4 stall in the ectoderm and fail to differentiate even in the presence of DAPT, an observation that does not support a primary role for FGF signaling in placodal downregulation of Notch signaling.
Notch inhibition disrupts basement membrane integrity only when FGF signaling is left intact
Analysis of embryos treated with DAPT revealed an undefined ectoderm in the opV region when compared to controls. A similar observation was made by Lassiter et al. (2010) . Because of growing interest in understanding tissue specific signals that regulate delamination events, we further investigated this finding by determining the effects of FGF and Notch signaling on basement membrane integrity. To do this, 12-14 ss embryos were treated with DMSO, SU5402, DAPT, or SU5402 plus DAPT and incubated on agar-albumin culture as previously described. After 24 hours, embryos were prepared, cryosectioned, and immunostained for Pax3, Islet1, and Laminin (Fig. 6) .
It was found that embryos treated with DAPT contained widely fragmented basement membrane in the placode region when compared to DMSO controls, as assayed by laminin staining (Fig. 6F ). Embryos treated with SU5402 and SU5402 + DAPT also contained small areas of basement membrane disruption, but not to the extent as that seen in DAPT treated embryos. This finding suggests that FGF activity along with Notch downregulation results in changes that disrupt basement membrane integrity in the opV placode.
Discussion
Sensory neuron development is a multi-step process involving several signaling pathways. Previous studies have found that Wnt, PDGF, FGF, and Notch are all involved in the process of sensory neurogenesis, but how these pathways interact to drive sensory neuron development had not been studied. We hypothesized that FGF and Notch interact in one of three possible mechanisms (Fig. 7) . By using a multifactorial approach, the FGF and Notch pathways were manipulated individually or simultaneously to help uncover the steps required to drive an undifferentiated opV placode cell to a proneural cell fate in the condensing opV ganglion. To test whether FGF activation leads to Notch downregulation, the use of the FGF receptor antagonist, SU5402, was employed to globally block FGF signaling with concurrent inhibition of Notch by DAPT. This approach allowed for the evaluation of all potential opV sensory neurons and was not dependent on electroporation efficiency. Further, by utilizing this method, embryos were not subjected to the additional impact of electroporation and it was not necessary to transfer embryos from one culture media to another, thus minimizing the chance of damaging the tissue. These results showed few cells co-expressing Pax3 and Islet1 in the mesenchyme, and showed that FGF inhibition resulted in failed neurogenesis, even in the context of Notch inhibition. Because FGF is involved in multiple developmental systems outside the opV placode, global FGF inhibition may have disrupted signals in a non-cell autonomous way. Therefore cell autonomous inhibition of FGF with sFGFR4 coupled with concurrent downregulation of Notch with DAPT was performed. sFGFR4-targeted cells remained in the ectoderm and did not express the proneural marker Islet1. It was therefore concluded that in normal sensory neurogenesis, FGF activation does not drive Notch downregulation to promote sensory neuron development. The fact that more Pax3+/ Islet1+ cells were found in the mesenchyme in SU5402 + DAPT treated embryos than in sFGFR4 + DAPT treated embryos was observed previously (Lassiter et al., 2009) , and is likely due to a less potent effect of SU5402 than sFGFR4. It was also observed that while combined downregulation of FGF and Notch disrupted normal neurogenesis (i.e. few Islet1 expressing cells in the mesenchyme), a qualitative assessment revealed that many Islet1 expressing cells were found in the mesenchyme of the maxillo-mandibular region (mmV) in embryos treated with DAPT alone and in embryos treated with SU5402 + DAPT. This finding may be significant if verified in rigorous followup studies, because it could reveal unique differences between the opV and mmV placodes in their requirement for FGF signaling.
In this study FGF signaling was blocked via two distinct mechanisms: with sFGFR4 and with SU5402. In both approaches, Notch signaling was also blocked with DAPT. This somewhat novel approach provides a framework wherein multiple signaling pathways can be manipulated simultaneously in the chick embryo. With the advent of new chemical inhibitors, these results help establish the efficacy of using multiple chemical inhibitors simultaneously, a technique that may have significant application in other research areas.
By assaying FGFR4 mRNA expression after treatment with DAPT, we were able to distinguish between the other two models: 1) Notch downregulation leading to the transient upregulation of FGFR4, and 2) FGF and Notch signaling working in parallel to promote neurogenesis (Fig. 7B,C) . If Notch downregulation resulted in transient FGFR4 upregulation, then we would expect to see expanded expression of FGFR4 mRNA after DAPT exposure (i.e. expression in a larger number of cells). Results from these experiments showed that FGFR4 expression was not enhanced by reduced Notch signaling. The combined results suggest that FGF and Notch signaling do not regulate one another in opV placode cells and are independently acting in ophthalmic trigeminal sensory neurogenesis. These findings are intriguing because Notch signaling is often viewed as a final regulatory switch for neuron formation (Gibb , 2010) . The data presented here do not negate the role of Notch signaling as the potential endpoint switch for neurogenesis, but indicate that other pathways must be maintained during this process. It will be interesting to evaluate the interface between Notch and Wnt signaling in this system, since Wnt was shown to be necessary for the maintenance of the placode cell fate, including the maintenance of Pax3 expression (Lassiter et al., 2007) .
As described, this study provides strong support for a parallel relationship between FGF and Notch signaling in regulating sensory neuron formation in the opV placode. In conjunction with other studies, the data presented here also supports the important role for both pathways in cellular delamination. Inhibition of FGF alone by misexpression of sFGFR4, or globally with SU5402, impeded cells from delaminating (also in Lassiter et al., 2009) . Similarly, a prior study demonstrated that constitutive Notch activation by misexpression of the Notch intracellular domain, NICD, inhibits delamination of cells in the opV placode (Lassiter et al., 2010) . Here, it was observed that few cells delaminated when FGF signaling was inhibited, even in the presence of Notch downregulation. Therefore, it appears that FGF signaling activity with concurrent Notch downregulation are both required for opV placode cell delamination. The data also provide evidence supporting the transient requirement for FGF signaling in the process of delamination/ differentiation. This comes from two observations: First, FGF8 misexpression alone does not lead to increased neuronal differentiation (Lassiter et al., 2009) . Second, treatment with SU5402 does not cause immediate and complete loss of Pax3 and Islet1 expression, demonstrating that cells are able to maintain neuronal potential without continual FGF signaling. FGF signaling is required, but the timing of signal transduction is regulated by the presence of the receptor, FGFR4, just at the time of cellular delamination. Perhaps cells that fail to delaminate due to FGF inhibition also fail to differentiate, supporting a model wherein delamination may be required for differentiation. The observation that Islet1 is expressed in a few placodal ectoderm cells prior to delamination is an important one (Dude et al., 2009) . Perhaps localized basement membrane breakdown is needed for cells to receive important differentiation signals. Ectodermal cells near a point of laminin fragmentation could be signaled to upregulated Islet1 while still in the ectoderm. In order to investigate the observation that DAPT treated embryos resulted in an undefined ectoderm, embryos were treated with DMSO, SU5402, DAPT, and SU5402 + DAPT and stained with Pax3, Islet1, and Laminin. While embryos treated with DAPT treatment alone resulted in a widely fragmented Laminin staining, embryos treated with SU5402 + DAPT did not. The important observation that basement membrane fragmentation occurs after Notch downregulation may help define the molecular events associated with trigeminal placode delamination. Because this effect was reversed in embryos treated with SU5402 + DAPT, FGF activation along with parallel Notch downregulation is likely required for basement membrane fragmentation, although the regulation may be indirect. It is known that delaminating neurogenic placode cells do not undergo epithelial-to-mesenchymal transition, rather they migrate as neuronal cells from breaks in the basal lamina (Graham et al., 2007) . Here we provide evidence for Notch regulation playing a role in this process. It may be difficult to determine how delamination and differentiation are linked molecularly.
These discoveries support a model wherein downregulation of Notch in coordination with activated FGF initiates changes that disrupt extracellular matrix proteins in the basement membrane, leading to fragmentation followed by delamination. Once parallel signaling by FGF and Notch has disrupted the basement membrane, continued quiescent Notch signaling, acting in coordination with other signals such as extracellular proteins, may then lead to neuronal differentiation (Fig. 8) . It has recently been shown that mammary epithelial EMT in mouse cells is regulated by extracellular basement membrane proteins where Laminin acts to inhibit EMT, and fibronectin promotes it (Chen et al., 2013) . While opV placode cell delamination does not undergo EMT, a similar mechanism may regulate trigeminal neuron differentiation. It is possible that once FGF and Notch signaling disrupt extracellular basement membrane proteins, opV cells begin to interact with some mesenchyme-restricted signal, possibly an extracellular matrix protein which, along with continued Notch downregulation, drives neurogenesis. Examining the effect of basement membrane breakdown and exposure of opV placode cells to extracellular matrix proteins will be an interesting focus of future research. Such research may help determine if quiescent Notch signaling in opV ectoderm cells, along with changes to cellular signaling due to basement membrane breakdown, drives sensory neurogenesis.
Experimental procedures
Preparation of embryos
Fertilized chicken eggs (Gallus gallus domesticus, White Leghorn) from a local farm were incubated at 38°C from 30 to 35 h to the 6-9 or 12-14 somite stage (ss). Once the embryos developed to the appropriate stage, the chick whole-embryo culture (Easy Chick, or EC) method developed by Susan Chapman et al. (2001) was used and adapted for these experiments. Each embryo was prepared by first cracking the egg into a Petri dish with the embryo facing up. The thick albumin surrounding the embryo was removed with a Kimwipe, and a ring of Whatman #2 paper with an outer diameter of 1.0 cm in and an inner diameter of 0.5 cm in was placed around the embryo so that the embryo was in the center of the ring. Scissors were used to cut the vitelline membrane around the outside of the ring. Each embryo was then lifted with the ring, and briefly placed in Simple Saline to rinse away excess yolk. After the yolk was removed, a second ring was placed on the ventral side of the embryo creating a sandwich of two rings with the embryo and vitelline membranes in the center. The embryos were then electroporated in the ring or placed into agar-albumen culture dishes with the control or chemical inhibitor and incubated to an appropriate later stage. This technique was developed as a variation of the EC culture method allowing for subsequent removal of the cultured embryo onto a new media.
Agar-albumen culture dishes with chemical inhibitor
Agar culture dishes are prepared according to Darnell and Schoenwolf (2000) and Chapman et al. (2001) . Briefly, 0.72 g of Bacto-Agar was mixed with 120 mL boiling saline solution (7.19 g NaCl/1 L distilled water that has been autoclaved) and put in a water bath at 49°C for 20 minutes. The solution was removed from the water bath and mixed with 120 mL of thin albumin and 120 µL of Penicillin/Streptomycin (10,000 units/mL) by swirling for 30-60 s in a flow hood. This solution was then mixed thoroughly with either N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester (DAPT; EMD Chemicals Inc., Cincinnati, OH; 200 µM), SU4502 (50 µM), dimethylsulfioxide (DMSO; Sigma-Aldrich Corp., St. Louis, MO), or SU5402 plus DAPT (at a concentration of 50 µM and 200 µM respectively) and placed in six-welled dishes so that 2 mL of agar/chemical solution was in each well. Culture dishes were then covered and allowed to solidify for at least 3 hours or to overnight at 4°C prior to use.
Electroporation of sFGFR4 and pCIG in whole-embryo explants
The secreted quail FGF receptor-4 (sFGFR4) was ligated into the RSV/pCL vector, which contains a separate SV40 promoter driving Green Fluorescent Protein (GFP; Scaal et al., 2004) . The sFGFR4 construct was a kind gift from Dr. Christophe Marcelle (Marics et al., 2002) . Both the pCIG and sFGFR4 constructs have an attached GFP reporter to identify targeted cells. DNA constructs were prepared to a concentration of approximately 5 µg/µL in water with fast green added for visualization. An electrode was placed under the head of the chicken embryo and the DNA/fast green solution was applied over the trigeminal placode region with a micropipette. Another electrode used to drive the DNA into the cells was then placed above the head and seven pulses at 10 ms each of 10 V was applied by a BTX 820 electroporator (Gentronics). Following electroporation, the rings containing the embryo were placed in agar wells con- taining DMSO. After a period of 4 hours, sufficient time for the electroporated constructs to become expressed, the embryos were moved to an agar well containing DAPT and allowed to incubate at 37°C for a total of 28 h to the 24-28 ss. After the incubation period each embryo was dissected from the ring, washed with phosphate-buffered saline (PBS), and fixed in 10 mL of 4% formaldehyde for 1 hour at room temperature or at 2-8°C overnight. Following fixation, embryos were washed three times with PBS, placed in 5% sucrose/PBS for 4 hours at room temperature, and then stored in 15% sucrose/PBS at 2-8°C until sectioning.
SU5402 and DAPT cultures
Embryos were grown to the 12-14 ss and prepared according to the modified EC culture method as described, placed on agar-albumin plates containing DMSO, SU5402, DAPT, or SU5402 plus DAPT, and incubated at 37°C for 24 h. Following the incubation period each embryo was dissected from the ring and prepared for cryosectioning in the same manner as electroporated embryos.
Immunohistochemistry
Embryos were prepared for cryosectioning by embedding them in gelatin consisting of 7.5 g gelatin (Sigma) and 15 g sucrose filled to a volume of 100 mL with 1X PBS. Each gelatin block was snap frozen in liquid nitrogen and sectioned at 12 µm prior to immunohistochemical staining for Pax3, Islet1 and laminin. The following primary antibodies were used: Pax3 (mouse IgG2a; Baker et al., 1999) , Islet-1 (mouse IgG2b; DSHB) and Laminin (Sigma L9393). Antibodies were properly diluted in antibody buffer (PBS, 0.1%, bovine serum albumin (BSA), 0.1% Tween® 20) and applied to each slide to incubate at 25°C for 4 hours or at 4°C overnight. Each slide was then washed and incubated with secondary antibody diluted in antibody buffer for 1 hour at 25°C. Following removal of the secondary antibody and washing, the slides were covered with VWR micro cover glass 24 × 60 mm No.1 and Fluoromount-G. Fluorescent images of the staining were taken at 20× or 40× with an Olympus BX61 microscope.
4.6.
In situ hybridization
Following culture with DAPT and incubation, experimental embryos undergoing in situ hybridization for FGFR4 mRNA expression were fixed in 4% formaldehyde and processed through a standard in situ hybridization protocol as generally described by Henrique et al. (1995) . Whole-mount embryos stained for specific mRNA transcripts and were then photographed and prepared for cryosectioning as described, and sectional imaging was performed with brightfield microscopy. The FGFR4 probe was generated using a 400 base pair fragment of chicken (Gallus gallus) FGFR4 cDNA, corresponding to base-pairs 54-454 of chicken FGFR4 (GenBank accession number AF083063), which was PCR-amplified from a cDNA library of homogenized 3-10 ss chick embryos using degenerate primers (5′-GGAGATGGAGCCAGACTCG-3′ and 5′-ACCTCTCCAGCACRTCCA-3′) and cloned into the pGEM-T easy vector (Promega).
Statistical analysis
Cell counts were performed on randomly selected opV placodes using the Olympus Microsuite software (Olympus, Center Valley, PA) similar to that previously described in Lassiter et al. (2007 Lassiter et al. ( , 2009 Lassiter et al. ( , 2010 . Cell counts for the electroporation experiments included cells expressing GFP, Islet1 antibody, and GFP and Islet1 antibody in the ectoderm and in the mesenchyme. Additional cell counts for SU5402 + DAPT culture experiments included cells expressing Pax3 antibody, Islet1 antibody, and Pax3 and Islet1 antibody in the ectoderm and mesenchyme. Tukey-Kramer tests were performed using SAS software, version 9.2 (SAS Institute Inc., Cary, NC) to determine which means between experimental and control groups differed significantly in the analysis of variance. A p-value of ≤0.05 was considered statistically significant.
